Artificial intelligence technologies in cardiology

Ł Ledziński, G Grześk - Journal of Cardiovascular Development and …, 2023 - mdpi.com
As the world produces exabytes of data, there is a growing need to find new methods that
are more suitable for dealing with complex datasets. Artificial intelligence (AI) has significant …

[HTML][HTML] Sodium tanshinone IIA sulfonate: a review of pharmacological activity and pharmacokinetics

ZY Zhou, WR Zhao, J Zhang, XL Chen… - Biomedicine & …, 2019 - Elsevier
Sodium tanshinone IIA sulfonate (STS) is a water-soluble derivate of tanshinone IIA (Tan IIA)
which is an active lipophilic constitute of Chinese Materia Medica Salvia miltiorrhiza …

A prognostic model for systemic lupus erythematosus-associated pulmonary arterial hypertension: CSTAR-PAH cohort study

J Qu, M Li, X Zhang, M Zhang, X Zuo, P Zhu, S Ye… - Respiratory …, 2023 - Springer
Background Pulmonary arterial hypertension is a major cause of death in systemic lupus
erythematosus, but there are no tools specialized for predicting survival in systemic lupus …

Clinical application of risk assessment in PAH: expert center APRN recommendations

M Wilson, J Keeley, M Kingman, S McDevitt… - Pulmonary …, 2022 - Wiley Online Library
Performing longitudinal and consistent risk assessments for patients with pulmonary arterial
hypertension (PAH) is important to help guide treatment decisions to achieve early on and …

Risk stratification in pulmonary arterial hypertension, update and perspectives

A Vraka, E Diamanti, M Kularatne, P Yerly… - Journal of Clinical …, 2023 - mdpi.com
Risk stratification in pulmonary arterial hypertension (PAH) is crucial in assessing patient
prognosis. It serves a prominent role in everyday patient care and can be determined using …

Легочная гипертензия как фактор оценки риска неблагоприятного исхода у пациентов с COVID-19

ЕЗ Голухова, ИВ Сливнева, ММ Рыбка… - Российский …, 2020 - cyberleninka.ru
Цель. Выяснение прогностической роли расчетного систолического давления в
легочной артерии у пациентов с новой коронавирусной инфекцией (COVID-19) …

[HTML][HTML] Pulmonary hypertension as a risk assessment factor for unfavorable outcome in patients with COVID-19

EZ Golukhova, IV Slivneva, MM Rybka… - Russian Journal of …, 2020 - russjcardiol.elpub.ru
Aim. To determine the predictive role of estimated pulmonary artery systolic pressure
(ePASP) in COVID-19 patients. Material and methods. A retrospective study of inpatients …

Applications of AI in cardiovascular disease detection—A review of the specific ways in which AI is being used to detect and diagnose cardiovascular diseases

SM Srinivasan, V Sharma - AI in Disease Detection …, 2025 - Wiley Online Library
The mixing of superior deep learning strategies has profoundly impacted the sector of
disease detection, promising sizable advancements in diagnostic accuracy and …

[HTML][HTML] Change in REVEAL Lite 2 risk score predicts outcomes in patients with pulmonary arterial hypertension in the PATENT study

RL Benza, A Boucly, HW Farber, AE Frost… - The Journal of Heart and …, 2022 - Elsevier
BACKGROUND: Risk assessment is essential in pulmonary arterial hypertension (PAH)
management. We investigated the effect of riociguat on REVEAL Lite 2 score, an abridged …

Influence of iron deficiency on clinical and haemodynamic parameters in pulmonary arterial hypertension cohorts

P Saluja, N Gautam, FNU Amisha, HM Salah… - Heart, Lung and …, 2022 - Elsevier
Background Iron deficiency (Fe def) has been shown to be common in patients with group 1
or pulmonary arterial hypertension (PAH). Several studies have shown a negative impact of …